ARID1A and neoplasm: In contrast to the phenotype observed in mice, Arid1a silencing only slightly enhanced the capacity of tumor cells to form organoids without significant alteration in proliferation (Fig. 1k, l), suggesting that TME-mediated mechanisms account for enhanced tumor progression in vivo.